Europe approves Amgen's first-in-class cholesterol drug

WASHINGTON (AP) — Amgen Inc. says European regulators have approved its first-of-a-kind cholesterol drug that lowers levels of the artery-clogging substance more than older drugs that have been prescribed for decades.